Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | KCNH3 | Q9ULD8 | 4/20 | 0.48 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.46 |
| ▸ | DNM2 | P50570 | 8/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31436050 | 1.00 | KMT2A (0.60) | KMT2AKCNH3SLC29A1DNM2LMNA | |
| SCHEMBL31436095 | 1.00 | KMT2A (0.60) | KMT2AKCNH3SLC29A1DNM2LMNA | |
| SCHEMBL31436106 | 1.00 | KMT2A (0.60) | KMT2AKCNH3SLC29A1DNM2LMNA | |
| SCHEMBL31436079 | 1.00 | KMT2A (0.60) | KMT2AKCNH3SLC29A1DNM2LMNA | |
| SCHEMBL31436064 | 1.00 | KMT2A (0.60) | KMT2AKCNH3SLC29A1DNM2LMNA | |
| SCHEMBL31436070 | 0.95 | KMT2A (0.58) | KMT2AKCNH3SLC29A1DNM2 | |
| SCHEMBL31436130 | 0.95 | KMT2A (0.58) | KMT2AKCNH3SLC29A1DNM2 | |
| SCHEMBL31436044 | 0.92 | KMT2A (0.67) | KMT2AKCNH3SLC29A1DNM2MEN1 | |
| SCHEMBL31436067 | 0.92 | KMT2A (0.67) | KMT2AKCNH3SLC29A1DNM2MEN1 | |
| SCHEMBL31436046 | 0.92 | KMT2A (0.56) | KMT2AKCNH3SLC29A1DNM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025088570-A1 | IONIZABLE LIPIDS AND IONIZABLE LIPID NANOPARTICLES | CRISPR THERAPEUTICS AG (CH) | 2025-05-01 | — | — | WO | disclosed |